The DISCOVER Study 3-Year Results: Feasibility and Usefulness of Microscope-Integrated Intraoperative OCT during Ophthalmic Surgery
Justis P Ehlers, Yasha S Modi, Paula E Pecen, Jeff Goshe, William J Dupps, Aleksandra Rachitskaya, Sumit Sharma, Alex Yuan, Rishi Singh, Peter K Kaiser, Jamie L Reese, Carmen Calabrise, Allison Watts, Sunil K Srivastava, Justis P Ehlers, Yasha S Modi, Paula E Pecen, Jeff Goshe, William J Dupps, Aleksandra Rachitskaya, Sumit Sharma, Alex Yuan, Rishi Singh, Peter K Kaiser, Jamie L Reese, Carmen Calabrise, Allison Watts, Sunil K Srivastava
Abstract
Purpose: To report the 3-year assessment of feasibility and usefulness of microscope-integrated intraoperative OCT (iOCT) during ophthalmic surgery.
Design: Prospective, consecutive case series.
Participants: Adult participants undergoing incisional ophthalmic surgery with iOCT imaging who consented to be enrolled in the Determination of Feasibility of Intraoperative Spectral-Domain Microscope Combined/Integrated OCT Visualization during En Face Retinal and Ophthalmic Surgery (DISCOVER) study.
Methods: The DISCOVER study is a single-site, multisurgeon, institutional review board-approved investigational device prospective study. Participants included patients undergoing anterior or posterior segment surgery who underwent iOCT imaging with 1 of 3 prototype microscope-integrated iOCT systems (i.e., Zeiss Rescan 700, Leica EnFocus, or Cole Eye iOCT systems). Clinical characteristics were documented, iOCT was directed by the operating surgeon at predetermined surgical time points, and each surgeon completed a questionnaire after surgery to evaluate the usefulness of iOCT during surgery.
Main outcome measures: Feasibility of iOCT based ability to obtain an OCT image during surgery and usefulness of iOCT based on surgeon reporting during surgery.
Results: Eight hundred thirty-seven eyes (244 anterior segment cases and 593 posterior segment cases) were enrolled in the DISCOVER study. Intraoperative OCT demonstrated feasibility with successful image acquisition in 820 eyes (98.0%; 95% confidence interval [CI], 96.8%-98.8%). In 106 anterior segment cases (43.4%; 95% CI, 37.1%-49.9%), the surgeons indicated that the iOCT information impacted their surgical decision making and altered the procedure. In posterior segment procedures, surgeons reported that iOCT enabled altered surgical decision making during the procedure in 173 cases (29.2%; 95% CI, 25.5%-33.0%).
Conclusions: The DISCOVER iOCT study demonstrated both generalized feasibility and usefulness based on the surgeon-reported impact on surgical decision making. This large-scale study confirmed similar findings from other studies on the potential value and impact of iOCT on ophthalmic surgery.
Conflict of interest statement
Conflict of Interest Statement: JPE and SKS have a license agreement with Bioptigen for an external mount system related to intraoperative OCT and a license option agreement with Synergetics related to the development OCT compatible surgical instruments. WJD performs sponsored research with Zeiss related to computational modeling of laser refractive surgery that is unrelated to the current study. None of these relationships are specifically related to the contents of this report. This relationship is not specifically relevant to the findings of the study. No other specific conflicts of interest exist related to this study for any of the other authors.
Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Figures
Source: PubMed